PAR 3.57% 27.0¢ paradigm biopharmaceuticals limited..

Fifty One Capital updated report, page-54

  1. 502 Posts.
    lightbulb Created with Sketch. 113
    I respectfully disagree Nano.

    IMO I would dismiss it. I've quite often found MS's reports to be questionable or wrong. I personally dont hold them in high regard.

    Example: Google - Morgan Stanley Lithium.

    There views on Lithium have been wrong and will continue to be wrong as the next 12-24 months unfold. There are plenty of articles challenging MS's report on Lithium.

    And they regularly have to admit to being wrong. Few examples:

    2018 - Apple, US Bond yields, Lithium

    2017 - stated that EV vehicles will takeover (then a yr later claimed lithium going down - doesnt make sense)

    - Gave $70m bad tax advice blunder

    2016 - Valeant Pharma

    2015 - Energy stocks and Tesla

    2014 - Qantas

    Plus they aren't independent at all. Google: 18-247MR ASIC requires Morgan Stanley

    IMHO. DYOR.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
27.0¢
Change
-0.010(3.57%)
Mkt cap ! $82.30M
Open High Low Value Volume
28.0¢ 28.0¢ 26.5¢ $281.4K 1.024M

Buyers (Bids)

No. Vol. Price($)
1 3499 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 161588 8
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.